RENAL IMPAIRMENT
Clinical trials for RENAL IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new RENAL IMPAIRMENT trials appear
Sign up with your email to follow new studies for RENAL IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Kidney drug combo study halted early
Disease control TerminatedThis study tested whether adding a new drug called AZD5462 to the standard medicine dapagliflozin could help people with both heart failure and moderate kidney disease. The trial was stopped early and only included 8 participants. The main goal was to see how the drug combination…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
Kidney-Friendly insulin showdown ends early: TRENT trial stopped
Disease control TerminatedThis study compared two long-acting insulins (Gla-300 and IDeg-100) in adults with type 2 diabetes and kidney disease who had never used insulin before. The goal was to see which one controls blood sugar better with fewer risks. The trial was stopped early, so results are limited…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Heart failure drug study halted early: did it help kidneys?
Knowledge-focused TerminatedThis study tested an experimental drug called AZD3427 to see if it could improve blood flow to the kidneys in people with heart failure and reduced kidney function. Only 10 participants were planned, but the study was terminated early. The main goal was to measure changes in kidn…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 08:57 UTC